A new study published by the University of Tufts in the United States said that, unlike the view that female breast cancer patients should not eat soy products, breast cancer patients can not only eat normal soy foods, but this may also reduce the risk of death in some patients. It is always controversial that breast cancer patients should not eat soy products because soy products contain phytoestrogens, soy isoflavones, and excessive levels of estrogen in the patients can cause the cells to overgrow, resulting in the occurrence or worsening of breast cancer. There is also the view that isoflavones will reduce the effect of hormone therapy for breast cancer. However, previous research on Asian women also found that isoflavones in soybeans can reduce the risk of breast cancer, reduce tumor recurrence, and improve survival. To that end, researchers at Tufts University analyzed data on more than 6,200 breast cancer patients in the United States and Canada. The average follow-up time for these patients was more than nine years. The results showed that those with high isoflavone diets had a 21% reduction in mortality compared with those with low isoflavone diets. Zhang Fangfang, an assistant professor at Tufts University in charge of the study, said that, regardless of whether patients receive hormone therapy, they and previous studies have not found that the dietary isoflavones may interfere with the treatment effect or have a negative impact on the patient's survival. On the contrary, "for patients with hormone receptor-negative tumors, ingesting soy foods may reduce the risk of death." According to Xinhua News Agency Led Soft Light Panel,Panel Soft Video Light,Soft Led Panel Light,Led Panel Soft Video Light EV LIGHT Guangzhou Co., Ltd , http://www.evlightprofessional.com